Press Releases Vor Biopharma Inc.

Equities

VOR

US9290331084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
1.225 ^USD	-3.16%		-9.26%	-45.56%

May. 13	Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating	MT
May. 09	Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Jun. 04	AQ
Vor Biopharma : ASGCT – 2024 – Poster Presentation 1775	May. 10	PU
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update	May. 09	AQ
Vor Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	May. 06	AQ
Vor Bio to Participate in Upcoming Investor Conferences	May. 06	AQ
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	May. 03	AQ
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors	May. 02	AQ
Vor Bio to Participate in Upcoming Investor Conferences	Apr. 01	AQ
Vor Biopharma : Bio Corporate Presentation March 2024	Mar. 20	PU
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update	Mar. 20	AQ
Vor Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	Mar. 06	AQ
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Mar. 05	AQ
Vor Bio to Participate in Upcoming Investor Conferences	Mar. 04	AQ
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 07	AQ
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Feb. 02	AQ
Vor Bio Doses First AML Patient with VCAR33 and Provides Corporate Update	Jan. 18	AQ
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update	Jan. 17	AQ
Vor Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	Dec. 22	AQ
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Dec. 21	AQ
Vor Biopharma : ASH – 2023 – POSTER PRESENTATION – 4862	Dec. 11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Vor Biopharma Inc.

Equities

VOR

US9290331084

Press Releases

Filters